Pharmaceuticals
Company Overview of Emergent Product Development Seattle, LLC
Company Overview
2401 4th Avenue
Suite 1050
Seattle, WA 98121
United States
Founded in 1999
73 Employees
Phone:
206-838-0500
Fax:
206-838-0503
Key Executives for Emergent Product Development Seattle, LLC
Emergent Product Development Seattle, LLC does not have any Key Executives recorded.
Emergent Product Development Seattle, LLC Key Developments
On December 21, 2011, Emergent BioSolutions Inc. and Emergent Product Development Seattle, LLC received written notification from Abbott Biotherapeutics Corp. of Abbott’s decision to terminate the collaboration and license agreement between the company and Abbott for the joint worldwide development and commercialization of TRU-016. Abbott informed the company that its decision was a result of its portfolio prioritization process. The termination will be effective on March 20, 2012, the ninetieth day after receipt of notice. TRU-016, Emergent’s humanized anti-CD37 mono-specific protein therapeutic, recently commenced a Phase 2 clinical study for chronic lymphocytic leukemia and is currently in Phase 1b clinical evaluation in non-Hodgkin’s lymphoma. These studies are expected to be completed, and final study data are expected to be available, in the first half of 2013. While the Agreement remains in effect, Abbott has an obligation to pay half of the collaboration project costs agreed to between the company and Abbott. Abbott also is obligated to pay the company milestone payments for milestone events achieved prior to March 20, 2012, including the $6 million milestone payment triggered by the company’s recent initiation of its Phase 2 clinical study of TRU-016 in CLL.
Similar Private Companies By Industry
| Company Name | Region |
| Polygenetics International Inc. | United States |
| NovaDigm Therapeutics, Inc. | United States |
| Cardiac Support Systems, Inc. | United States |
| Decision Resources, LLC | United States |
| Ixion Biotechnology, Inc. | United States |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| NYC2012, Inc. | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Chapel Hill, NC | Cempra PharmaceuticalsPosted: Jun 11
- Connecticut | Boehringer IngelheimPosted: May 27
- Great Falls, MT | AstraZenecaPosted: Jun 17
- Miami Beach, FL | Pain Fiber Nerve Conduction StudiesPosted: Jun 17
Sponsored Financial Commentaries
Sponsored Links
To contact Emergent Product Development Seattle, LLC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
